Universität zu Lübeck

Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination (2022) Irrgang P, Gerling J, Kocher K, Lapuente D, Steininger P, Habenicht K, Wytopil M, et al. Journal article Immune checkpoint inhibition and targeted therapy for melanoma: A patient-oriented cross-sectional comparative multicentre study (2022) Thiem A, Mashhadiakbar P, Cussigh C, Hassel JC, Grimmelmann I, Gutzmer R, Schlaak M, et al. Journal article Special issue: AUTOMED 2021: Automation in Medical Technology (2022) Rauter G, Seel T, Rostalski P Journal article, Editorial S2k Guideline for the diagnosis and treatment of mucous membrane pemphigoid (2022) Hofmann SC, Gunther C, Bockle BC, Didona D, Ehrchen J, Gaskins M, Geerling G, et al. Journal article Epidemiology of inherited epidermolysis bullosa in Germany (2022) Has C, Hess M, Anemueller W, Blume-Peytavi U, Emmert S, Foelster-Holst R, Frank J, et al. Journal article Therapeutic effects of Fc gamma RIV inhibition are mediated by selectively blocking immune complex-induced neutrophil activation in epidermolysis bullosa acquisita (2022) Haeger SC, Kridin K, Pieper M, Griewahn L, Nimmerjahn F, Zillikens D, König P, et al. Journal article Real-world clinical outcomes of pembrolizumab for advanced melanoma in the German ADOREG skin cancer registry (2022) Mohr P, Scherrer E, Alar V, Assaf C, Beissert S, Berking C, Eigentler T, et al. Conference contribution Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody (2022) Gehlert CL, Rahmati P, Boje AS, Winterberg D, Krohn S, Theocharis T, Cappuzzello E, et al. Journal article [YIA] AMPLIFICATION OF ROS/NET FORMATION INDUCES RESOLUTION OF INFLAMMATION (2022) Euler M, Hahn J, Herrmann M, Mokhir A, Hoffmann M Conference contribution Not Simply a Structural Problem: Psychological Determinants of Headache in Patients with Tumors of the Sellar Region (2022) Siegel S, Schenk T, Brabant G, Scholl RC, Buchfelder M, Kreitschmann-Andermahr I Journal article